G
Geltor
Synthetic biology working towards a vegan gelatin replacement
About Geltor
Geltor is a biotech startup that specializes in the design and production of animal-free proteins for use in beauty, wellness, and other industries. The company operates in the growing market of sustainable and vegan-friendly products, catering to consumers who are increasingly conscious of the environmental and ethical implications of their purchases.
Geltor's business model revolves around the use of biodesign and fermentation to create proteins that mimic the properties of animal-derived ingredients, such as collagen, but without the associated ethical and environmental issues. These proteins are then sold to manufacturers for use in their products, providing Geltor with a steady revenue stream.
The company's flagship products include Caviance™, a type II collagen for topical use, and NuColl™, a protein designed for hair care. Both of these products are made using precision fermentation, a process that involves using microorganisms to produce specific proteins, and are designed to offer a sustainable and animal-free alternative to conventional collagens.
Geltor prides itself on its commitment to sustainability and its ability to deliver novel, commercially-viable proteins with speed and accuracy. The company's integrated platform starts and ends with the needs of its customers, leveraging expert biodesign, fermentation, claim substantiation, and formulation know-how to create and deliver its products.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Leandro, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 78.3/100
- Industry
- Wellness Beauty
- Sector
- Wellness Beauty, Personal Health, Beauty, Biotechnology, Genetics and genomics, GMO, Synthetic Biology, Plant-Based, Genome Engineering, Alternative Protein, Sustainable Development Goals
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2025 | $0 | — | iSelect Fund · Starlight Ventures | ↗ |
| CONVERTIBLEOther financing | May 2023 | $0 | — | Indie Bio · SOSV | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Geltor is 2.1K monthly website visits, down 48.8% over the last three months. Geltor's team declined 5.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Indie Bio
SOSV
Fifty Years
New Crop Capital
Stray Dog Capital
Baruch Future Ventures
FTW Ventures
Blue Horizon
Series A8 investors entered at this stage
Cultivian Sandbox Ventures
Starlight Ventures
CPT Capital
Pegasus Tech Ventures
iSelect Fund
RIT Capital Partners
Archer Daniels Midland- BIBeyond Investing
Series B and later1 investor entered at this stage
Agronomics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Geltor on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Geltor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.